The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback